WallStreetZenWallStreetZen

NASDAQ: TBIO
Telesis Bio Inc Stock

$0.35+0.03 (+9.38%)
Updated Feb 21, 2024
Why Price Moved
TBIO Price
$0.35
Fair Value Price
N/A
Market Cap
$10.55M
52 Week Low
$0.30
52 Week High
$3.32
P/E
-0.27x
P/B
0.59x
P/S
1.04x
PEG
N/A
Dividend Yield
N/A
Revenue
$30.00M
Earnings
-$38.17M
Gross Margin
62.2%
Operating Margin
-122.04%
Profit Margin
-129.6%
Debt to Equity
3.3
Operating Cash Flow
-$33M
Beta
1.42
Next Earnings
Mar 19, 2024
Ex-Dividend
N/A
Next Dividend
N/A

TBIO Overview

Codex DNA, Inc. manufactures and sells synthetic biology instruments, reagents, associated products, and provides related services to pharmaceutical and academic laboratories worldwide. Its solutions and products include BioXp, BioXp portal, BioXp kits, Cloud-based scripts, Benchtop reagents, and Biofoundry Services. Known as SGI-DNA, Inc.until 2020/03, Codex DNA was incorporated in 2011 and is headquartered in San Diego, CA.

Zen Score

Industry Average (26)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how TBIO scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

TBIO is unprofitable, so we are unable to calculate its intrinsic value according to an updated version of Benjamin Graham's Formula from "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
TBIO is good value based on its book value relative to its share price (0.59x), compared to the US Medical Devices industry average (4.02x)
P/B vs Industry Valuation
TBIO is unprofitable, so we... subscribe to Premium to read more.
PEG Value Valuation
There are 30 more TBIO due diligence checks available for Premium users.

Be the first to know about important TBIO news, forecast changes, insider trades & much more!

Valuation

TBIO price to earnings (PE)

For valuing profitable companies with steady earnings
Company
-0.27x
Industry
36.28x
Market
28.8x

TBIO price to book (PB)

For valuing companies that are loss-making or have lots of physical asset
Company
0.59x
Industry
4.02x
TBIO is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation

TBIO's financial health

Profit margin

Revenue
$5.6M
Net Income
-$10.6M
Profit Margin
-201.3%
TBIO's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials
TBIO's profit margin has increased... subscribe to Premium to read more.
Profit Margin Growth Financials

Assets to liabilities

Assets
$105.0M
Liabilities
$58.5M
Debt to equity
3.3
TBIO's short-term assets ($52.71M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
TBIO's short-term assets ($52.71M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
TBIO's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
-$5.9M
Investing
-$23.2M
Financing
-$101.0k
TBIO's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials

TBIO vs Medical Device Stocks

TickerMarket Cap1d %P/EP/B
TBIO$10.55M+11.75%-0.27x0.59x
BTCY$11.30M+4.01%-0.70x-0.41x
INBS$8.68M-4.72%-0.04x2.65x
DHAI$12.90M0.00%-2.52x-1.16x
OSA$8.04M-24.03%-0.35x-0.24x

Telesis Bio Stock FAQ

What is Telesis Bio's quote symbol?

(NASDAQ: TBIO) Telesis Bio trades on the NASDAQ under the ticker symbol TBIO. Telesis Bio stock quotes can also be displayed as NASDAQ: TBIO.

If you're new to stock investing, here's how to buy Telesis Bio stock.

What is the 52 week high and low for Telesis Bio (NASDAQ: TBIO)?

(NASDAQ: TBIO) Telesis Bio's 52-week high was $3.32, and its 52-week low was $0.30. It is currently -89.4% from its 52-week high and 17.33% from its 52-week low.

How much is Telesis Bio stock worth today?

(NASDAQ: TBIO) Telesis Bio currently has 29,983,709 outstanding shares. With Telesis Bio stock trading at $0.35 per share, the total value of Telesis Bio stock (market capitalization) is $10.55M.

Telesis Bio stock was originally listed at a price of $18.50 in Jun 18, 2021. If you had invested in Telesis Bio stock at $18.50, your return over the last 2 years would have been -98.1%, for an annualized return of -86.21% (not including any dividends or dividend reinvestments).

How much is Telesis Bio's stock price per share?

(NASDAQ: TBIO) Telesis Bio stock price per share is $0.35 today (as of Feb 21, 2024).

What is Telesis Bio's Market Cap?

(NASDAQ: TBIO) Telesis Bio's market cap is $10.55M, as of Feb 23, 2024.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Telesis Bio's market cap is calculated by multiplying TBIO's current stock price of $0.35 by TBIO's total outstanding shares of 29,983,709.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.